These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 23906582)
1. [A case of dysfibrinogenemia without hemorrhagic diathesis or thromboembolism linked to a new mutation p.H103N in fibrinogen γ chain]. Devignes J; Hanss M; Chabaud A; Toussaint-Hacquard M; Mansuy L; De Mazancourt P; Lecompte T Ann Biol Clin (Paris); 2013; 71(4):489-95. PubMed ID: 23906582 [TBL] [Abstract][Full Text] [Related]
2. Fibrinogen Nový Jicín and Praha II: cases of hereditary Aalpha 16 Arg-->Cys and Aalpha 16 Arg-->His dysfibrinogenemia. Kotlín R; Chytilová M; Suttnar J; Riedel T; Salaj P; Blatný J; Santrůcek J; Klener P; Dyr JE Thromb Res; 2007; 121(1):75-84. PubMed ID: 17408725 [TBL] [Abstract][Full Text] [Related]
3. Fibrinogen Šumperk II: dysfibrinogenemia in an individual with two coding mutations. Kotlín R; Suttnar J; Cápová I; Hrachovinová I; Urbánková M; Dyr JE Am J Hematol; 2012 May; 87(5):555-7. PubMed ID: 22407772 [TBL] [Abstract][Full Text] [Related]
4. A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis. Robert-Ebadi H; Le Querrec A; de Moerloose P; Gandon-Laloum S; Borel Derlon A; Neerman-Arbez M Blood Coagul Fibrinolysis; 2008 Oct; 19(7):697-9. PubMed ID: 18832913 [TBL] [Abstract][Full Text] [Related]
5. A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release. Yan J; Luo M; Cheng P; Liao L; Deng X; Deng D; Lin F Int J Hematol; 2017 Apr; 105(4):506-514. PubMed ID: 27933517 [TBL] [Abstract][Full Text] [Related]
6. A case of congenital afibrinogenemia: fibrinogen Hakata, a novel nonsense mutation of the fibrinogen gamma-chain gene. Iida H; Ishii E; Nakahara M; Urata M; Wakiyama M; Kurihara M; Watanabe K; Kai T; Ihara K; Kinoshita S; Hamasaki N Thromb Haemost; 2000 Jul; 84(1):49-53. PubMed ID: 10928469 [TBL] [Abstract][Full Text] [Related]
7. Three cases of congenital dysfibrinogenemia in unrelated Chinese families: heterozygous missense mutation in fibrinogen alpha chain Argl6His. Luo M; Deng D; Xiang L; Cheng P; Liao L; Deng X; Yan J; Lin F Medicine (Baltimore); 2016 Sep; 95(39):e4864. PubMed ID: 27684817 [TBL] [Abstract][Full Text] [Related]
9. Fibrinogen Guarenas, an abnormal fibrinogen with an Aalpha-chain truncation due to a nonsense mutation at Aalpha 467 Glu (GAA)-->stop (TAA). Marchi R; Carvajal Z; Meyer M; Soria J; Ruiz-Saez A; Arocha-Piñango CL; Weisel JW Thromb Res; 2006; 118(5):637-50. PubMed ID: 16406498 [TBL] [Abstract][Full Text] [Related]
10. Dysfibrinogenemia in childhood: two cases of congenital dysfibrinogens. Kotlín R; Blažek B; Suttnar J; Malý M; Kvasnička J; Dyr JE Blood Coagul Fibrinolysis; 2010 Oct; 21(7):640-8. PubMed ID: 20829681 [TBL] [Abstract][Full Text] [Related]
11. Two cases of congenital dysfibrinogenemia associated with thrombosis - Fibrinogen Praha III and Fibrinogen Plzen. Kotlín R; Reicheltová Z; Malý M; Suttnar J; Sobotková A; Salaj P; Hirmerová J; Riedel T; Dyr JE Thromb Haemost; 2009 Sep; 102(3):479-86. PubMed ID: 19718467 [TBL] [Abstract][Full Text] [Related]
12. Two novel mutations in the fibrinogen γ nodule. Kotlín R; Pastva O; Stikarová J; Hlaváčková A; Suttnar J; Chrastinová L; Riedel T; Salaj P; Dyr JE Thromb Res; 2014 Oct; 134(4):901-8. PubMed ID: 25074738 [TBL] [Abstract][Full Text] [Related]
13. Dysfibrinogenemia (fibrinogen Wilmington) due to a novel Aalpha chain truncation causing decreased plasma expression and impaired fibrin polymerisation. Brennan SO; Mosesson MW; Lowen R; Frantz C Thromb Haemost; 2006 Jul; 96(1):88-9. PubMed ID: 16807657 [No Abstract] [Full Text] [Related]
14. Molecular characterization of 7 patients affected by dys- or hypo-dysfibrinogenemia: Identification of a novel mutation in the fibrinogen Bbeta chain causing a gain of glycosylation. Asselta R; Robusto M; Platé M; Santoro C; Peyvandi F; Duga S Thromb Res; 2015 Jul; 136(1):168-74. PubMed ID: 26006300 [TBL] [Abstract][Full Text] [Related]
16. A novel fibrinogen variant: dysfibrinogenemia associated with γAsp185Asn substitution. Zhou N; Xu P; Zhou M; Xu Y; Li P; Chen B; Ouyang J; Zhou R J Thromb Thrombolysis; 2017 Jul; 44(1):139-144. PubMed ID: 28425010 [TBL] [Abstract][Full Text] [Related]
17. Two novel fibrinogen variants in the C-terminus of the Bβ-chain: fibrinogen Rokycany and fibrinogen Znojmo. Kotlín R; Reicheltová Z; Suttnar J; Salaj P; Hrachovinová I; Riedel T; Malý M; Oravec M; Kvasnicka J; Dyr JE J Thromb Thrombolysis; 2010 Oct; 30(3):311-8. PubMed ID: 20640913 [TBL] [Abstract][Full Text] [Related]
18. Congenital hypofibrinogenemia associated with novel heterozygous fibrinogen Bbeta and gamma chain mutations. Castaman G; Giacomelli SH; Duga S; Rodeghiero F Haemophilia; 2008 May; 14(3):630-3. PubMed ID: 18393984 [No Abstract] [Full Text] [Related]
19. Paris I dysfibrinogenemia: a point mutation in intron 8 results in insertion of a 15 amino acid sequence in the fibrinogen gamma-chain. Rosenberg JB; Newman PJ; Mosesson MW; Guillin MC; Amrani DL Thromb Haemost; 1993 Mar; 69(3):217-20. PubMed ID: 8470043 [TBL] [Abstract][Full Text] [Related]
20. Afibrinogenemia resulting from homozygous nonsense mutation in A alpha chain gene associated with multiple thrombotic episodes. Simsek I; de Mazancourt P; Horellou MH; Erdem H; Pay S; Dinc A; Samama MM Blood Coagul Fibrinolysis; 2008 Apr; 19(3):247-53. PubMed ID: 18388508 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]